Trials / Conditions / Recurrent World Health Organization (WHO) Grade II Glioma
Recurrent World Health Organization (WHO) Grade II Glioma
3 registered clinical trials studyying Recurrent World Health Organization (WHO) Grade II Glioma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) NCT04485559 | University of California, San Francisco | Phase 1 |
| Completed | Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms NCT04044937 | Thomas Hope | Phase 2 |
| Recruiting | Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma NCT04540107 | Susan Chang | Phase 1 |